Niva Bupa Health Insurance Company Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Niva Bupa Health Insurance Company Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Niva Bupa Health Insurance Company shares trading at Rs.86 against a market capitalisation of Rs.15,924 Cr and a price-to-earnings multiple of 121.3. As an insurance name on the NSE and BSE, Niva Bupa Health Insurance Company enters the Niva Bupa Health Insurance Company Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.

Quarterly financials for Niva Bupa Health Insurance Company are not yet fully available on Univest’s data partners for this cycle; investors should track Screener.in and the NSE/BSE filings directly for the Niva Bupa Health Insurance Company Q1 Results FY27 result date and cross-check any figures before making investment decisions.

Get Free Investment Predictions and Niva Bupa Health Insurance Company Research at Univest

Niva Bupa Health Insurance Company (NSE: NIVABUPA) operates in the insurance space and is tracked on Univest under its NSE and BSE listings ahead of the Niva Bupa Health Insurance Company Q1 Results FY27 season, forming the base against which the Niva Bupa Health Insurance Company Q1 Results FY27 estimates in this article are built. This Niva Bupa Health Insurance Company Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.

Niva Bupa Health Insurance Company Q1 FY27 Estimates

Metric	Detail
CMP	Rs.86
Market Cap	Rs.15,924 Cr
Results Date	July-August 2026 (indicative)
12-Month Target (Uniresearch Estimate)	Rs.87-98

Univest, a SEBI-Registered Investment Advisor, Tracks Niva Bupa Health Insurance Company Ahead of Q1 FY27 Results

Key Catalysts to Watch

1. Premium Growth

Premium growth in the retail and group segments supporting topline momentum is one of the primary variables that analysts are tracking ahead of Niva Bupa Health Insurance Company’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Niva Bupa Health Insurance Company share price target or faces renewed pressure.

2. Claims and Combined Ratio

Improving claims ratio and combined ratio trends aiding underwriting profitability is one of the primary variables that analysts are tracking ahead of Niva Bupa Health Insurance Company’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Niva Bupa Health Insurance Company share price target or faces renewed pressure.

3. Distribution Expansion

Distribution expansion through bancassurance and digital channels widening reach is one of the primary variables that analysts are tracking ahead of Niva Bupa Health Insurance Company’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Niva Bupa Health Insurance Company share price target or faces renewed pressure.

Download the Univest iOS App or Univest Android App to track Niva Bupa Health Insurance Company’s live price and Q1 FY27 result updates.

Key Risks to the Niva Bupa Health Insurance Company Q1 Results FY27 Outlook

• Elevated claims ratio from adverse claims experience in the quarter.
• Regulatory changes to surrender value or commission norms affecting margins.
• Slower premium growth if macro or distribution headwinds persist.

Q4 FY26 Performance Context

Detailed Q4 FY26 financials for Niva Bupa Health Insurance Company were not available from Univest’s data partners at the time of writing. Investors should check Screener.in or the company’s exchange filings for the latest verified numbers before the Q1 FY27 results.

Technical Analysis Ahead of Niva Bupa Health Insurance Company Q1 Results FY27

Niva Bupa Health Insurance Company shares last traded at Rs.86. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.

Share Price Target Based on the Niva Bupa Health Insurance Company Q1 Results FY27 Outlook

3-6 Month Target

Over a 3-6 month horizon, the Niva Bupa Health Insurance Company Q1 Results FY27 trailing-growth framework points to a range of Rs.85-91 for Niva Bupa Health Insurance Company, contingent on the Niva Bupa Health Insurance Company Q1 Results FY27 print matching or beating the trailing growth trend.

12-Month Target

The 12-month target (Uniresearch estimate) tied to this Niva Bupa Health Insurance Company Q1 Results FY27 view for Niva Bupa Health Insurance Company works out to Rs.87-98, built on the same trailing revenue growth trend and current valuation multiple. Tracking is how Univest research categorises the stock heading into Niva Bupa Health Insurance Company Q1 Results FY27, not a formal Buy or Sell call.

FY27-28 Outlook

Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Niva Bupa Health Insurance Company Q1 Results FY27 analysis would put Niva Bupa Health Insurance Company in a Rs.92-107 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.

What to Watch in the Niva Bupa Health Insurance Company Q1 Results FY27 Print

• Revenue and PAT versus the Niva Bupa Health Insurance Company Q1 Results FY27 estimate range in this preview.
• Management commentary on FY27 growth guidance and margin trajectory relevant to the Niva Bupa Health Insurance Company Q1 Results FY27 narrative.
• Premium growth in the retail and group segments supporting topline momentum
• Elevated claims ratio from adverse claims experience in the quarter

Conclusion on Niva Bupa Health Insurance Company Q1 Results FY27

Niva Bupa Health Insurance Company enters the Q1 FY27 results season trading at Rs.86, with the 12-month Uniresearch target range of Rs.87-98 reflecting a tracking stance. Investors tracking the Niva Bupa Health Insurance Company Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.

FAQs on Niva Bupa Health Insurance Company Q1 Results FY27

When are Niva Bupa Health Insurance Company Q1 FY27 results expected?

Ans. Niva Bupa Health Insurance Company’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.

What is the Niva Bupa Health Insurance Company Q1 FY27 revenue estimate?

Ans. Detailed quarterly estimates are not available for Niva Bupa Health Insurance Company at this time; check Screener.in or the company’s exchange filings for verified numbers.

What is the Niva Bupa Health Insurance Company share price target?

Ans. The 12-month Uniresearch estimate for Niva Bupa Health Insurance Company share price target is Rs.87-98, based on trailing growth and current valuation multiples.

Is Niva Bupa Health Insurance Company a good buy before Q1 FY27 results?

Ans. Niva Bupa Health Insurance Company is tracking heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.

What should investors watch in Niva Bupa Health Insurance Company’s Q1 FY27 results?

Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and premium growth in the retail and group segments supporting topline momentum.

Where can I track Niva Bupa Health Insurance Company share price live?

Ans. Niva Bupa Health Insurance Company share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.